Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury
Abstract The prognosis of the liver transplant patients was frequently deteriorated by ischemia and reperfusion injury (IRI) in the liver. Infiltration of inflammatory cells is reported to play critical roles in the pathogenesis of hepatic IRI. Although T lymphocytes, neutrophils and monocytes infil...
Guardado en:
Autores principales: | Enzhi Yin, Takeshi Fukuhara, Kazuyoshi Takeda, Yuko Kojima, Kyoko Fukuhara, Kenichi Ikejima, Hisashi Bashuda, Jiro Kitaura, Hideo Yagita, Ko Okumura, Koichiro Uchida |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da75a8a7537b4d3791b95e3244b60239 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acta Nº321
por: Banco Central de Chile
Publicado: (2019) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Songhyun Lim, et al.
Publicado: (2021) -
Transcriptional changes during hepatic ischemia-reperfusion in the rat.
por: Valerie Zabala, et al.
Publicado: (2019) -
Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
por: Marya Morevati, et al.
Publicado: (2021) -
Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats
por: Jacob Marthinsen Seefeldt, et al.
Publicado: (2021)